Streetbeat News

Earnings

AZZ

AZZ Inc. (NYSE:AZZ) has updated its FY25 financial guidance, increasing its sales forecast to $1.525B-$1.625B from the previous $1.5B-$1.6B, and its adjusted EPS to $4.50-$5.00 from $4.25-$4.75. This revision reflects a positive outlook for the fiscal year 2025.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 10:36 am

INZY

Inozyme Pharma, Inc. (NASDAQ:INZY) announced positive topline data from ongoing Phase 1/2 clinical trials of INZ-701 for treating ABCC6 Deficiency (PXE) and ENPP1 Deficiency. The data includes safety, pharmacokinetic (PK), pharmacodynamic (PD), and exploratory efficacy results.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 10:31 am

PERI

Perion Network's shares dropped following the company's announcement of reduced FY24 revenue guidance and a Q1 outlook that fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 10:16 am

PERI

Perion Network Ltd. (PERI) announced preliminary Q1 2024 financial results and updated its full year 2024 guidance, citing a decline in Search Advertising activity due to changes in Microsoft Bing's advertising pricing and mechanisms. Q1 revenue is expected to be $157M, with full year revenue forecasted between $590M-$610M, a significant decrease from prior estimates. The company attributes the decline mainly to Search Advertising and, to a lesser extent, web video activity. Despite this, Perion's CEO emphasized the company's strong relationship with Microsoft, its diversified digital advertising solutions, and the growth in Display Advertising. Perion also increased its buyback program from $50M to $75M.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 10:05 am

FSM

Fortuna Silver Mines Inc. (NYSE:FSM) reported strong Q1 2024 gold and gold equivalent production of 112,543 ounces from its operations in West Africa and Latin America. The company also reiterated its 2024 production guidance of 343 to 385 thousand ounces of gold and 4.0 to 4.7 million ounces of silver, totaling 457 to 497 thousand gold equivalent ounces, including lead and zinc by-products.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 9:02 am

CVU

CPI Aerostructures (AMEX:CVU) reported a significant increase in Q4 EPS to $1.20, up from $0.03 YoY, despite a slight decrease in sales to $23.50M from $24.08M YoY.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 7:39 am

CVU

CPI Aerostructures (AMEX:CVU) reported a significant increase in Q4 adjusted EPS to $0.09, up from $0.03 YoY, despite a slight decrease in sales to $23.50M from $24.08M YoY. The EPS increase is notable even when excluding the impact of deferred tax asset valuation allowance reductions.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 7:37 am

OCUL

Ocular Therapeutix announced positive Phase 2 data for PAXTRAVA in treating glaucoma, showing significant IOP reductions and good tolerance, at the ASCRS 2024 Annual Meeting. The data suggests potential for repeat dosing due to consistent durability and bioresorption of the implant.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 7:27 am

ACN

AGEN

BRAG

LOT

RDCM

Accenture plc (ACN) is acquiring CLIMB to expand its technology capabilities, with shares slightly up in after-hours trading. Agenus Inc. (AGEN) announced a 1-for-20 reverse stock split, causing a share price drop. Lotus Technology Inc. (LOT) is set to report Q4 financial results before April 8, 2024, with a slight share price increase. RADCOM Ltd. (RDCM) announced a CEO change, leading to a share price decrease. Bragg Gaming Group Inc. (BRAG) reported the resignation of its CFO, with shares slightly up.

Portfolio Pulse from Avi Kapoor

April 08, 2024 | 7:19 am

BMY

Bristol Myers Squibb presented new interim long-term efficacy data from the EMERGENT-4 trial for KarXT in schizophrenia at the 2024 SIRS Congress, showing continued improvements in symptoms at 52 weeks, with over 75% of participants achieving more than 30% improvement.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 7:11 am